Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:19 AM
Ignite Modification Date:
2025-12-25 @ 1:19 AM
NCT ID:
NCT00002393
Eligibility Criteria:
Inclusion Criteria
Patients must have:
* CD4+ cell count of at least 50 cells/mm3.
* HIV RNA level of at least 10,000 copies/ml by reverse transcriptase polymerase chain reaction (RT-PCR, Amplicor test kit) at screening.
* Signed, informed consent from parent or legal guardian for patients less than 18 years of age.
Exclusion Criteria
Prior Medication:
Excluded:
* DMP 266.
* Other nonnucleoside reverse transcriptase inhibitors.
Required:
One or two NRTIs (except ZDV and d4T in combination) for a minimum of 8 weeks, within 12 weeks prior to screening.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
13 Years
Maximum Age:
60 Years
Study:
NCT00002393
Study Brief:
Protocol Section:
NCT00002393